Baidu
map

核酸检测样本不合格和检测结果可疑有什么区别?上海卫健委回应

2021-02-02 央视新闻客户端 央视新闻客户端

在今天(26日)下午举行的上海市疫情防控工作新闻发布会上,有记者提问,昨晚上海红房子妇产科医院通报,该院在核酸检测中发现个别不合格样本,不合格样本与此前核酸检测结果可疑有什么区别?

在今天(26日)下午举行的上海市疫情防控工作新闻发布会上,有记者提问,昨晚上海红房子妇产科医院通报,该院在核酸检测中发现个别不合格样本,不合格样本与此前核酸检测结果可疑有什么区别?

上海市卫健委主任邬惊雷介绍,任何检测样本的采集、运送、处理、检测都有规范和标准,医院在检测流程中,发现标本不合格,这和检测结果可疑是不一样的。如果采集的标本不合格,就没法进行测试。

昨天红房子发现标本不合格,就马上进行重新采样,进行平行复核。最终结果大家看到了,该院对1月25日全院例行新冠肺炎核酸检测的复核工作已完成,均为阴性,我们及时回应了社会关切。

在防疫工作中,采样、消杀的人员穿着大白衣服,大家不必惊慌,希望市民相信我们的专业处置,相信相关部门会及时公开透明。出现一些情况,到最终作出科学评判,肯定会有时间差,希望大家理解,给我们时间作出准确判断,解疑释惑。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1669469, encodeId=71af166946904, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Wed Feb 24 11:01:21 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083715, encodeId=88c32083e15cc, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Tue May 25 05:01:21 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668970, encodeId=d94216689e07f, content=<a href='/topic/show?id=1086203266c' target=_blank style='color:#2F92EE;'>#不合格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20326, encryptionId=1086203266c, topicName=不合格)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77c26479803, createdName=echonoir, createdTime=Fri Jun 11 15:01:21 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922664, encodeId=2d9492266492, content=什么一起<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ec5456575, createdName=ms5000001852640370, createdTime=Thu Feb 04 00:54:54 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258792, encodeId=b34b1258e92ff, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Feb 03 16:01:21 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922141, encodeId=a7a4922141c1, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43995458008, createdName=ms2000001236693715, createdTime=Tue Feb 02 10:22:45 CST 2021, time=2021-02-02, status=1, ipAttribution=)]
    2021-02-24 zhzhxiang
  2. [GetPortalCommentsPageByObjectIdResponse(id=1669469, encodeId=71af166946904, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Wed Feb 24 11:01:21 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083715, encodeId=88c32083e15cc, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Tue May 25 05:01:21 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668970, encodeId=d94216689e07f, content=<a href='/topic/show?id=1086203266c' target=_blank style='color:#2F92EE;'>#不合格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20326, encryptionId=1086203266c, topicName=不合格)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77c26479803, createdName=echonoir, createdTime=Fri Jun 11 15:01:21 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922664, encodeId=2d9492266492, content=什么一起<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ec5456575, createdName=ms5000001852640370, createdTime=Thu Feb 04 00:54:54 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258792, encodeId=b34b1258e92ff, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Feb 03 16:01:21 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922141, encodeId=a7a4922141c1, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43995458008, createdName=ms2000001236693715, createdTime=Tue Feb 02 10:22:45 CST 2021, time=2021-02-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1669469, encodeId=71af166946904, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Wed Feb 24 11:01:21 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083715, encodeId=88c32083e15cc, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Tue May 25 05:01:21 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668970, encodeId=d94216689e07f, content=<a href='/topic/show?id=1086203266c' target=_blank style='color:#2F92EE;'>#不合格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20326, encryptionId=1086203266c, topicName=不合格)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77c26479803, createdName=echonoir, createdTime=Fri Jun 11 15:01:21 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922664, encodeId=2d9492266492, content=什么一起<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ec5456575, createdName=ms5000001852640370, createdTime=Thu Feb 04 00:54:54 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258792, encodeId=b34b1258e92ff, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Feb 03 16:01:21 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922141, encodeId=a7a4922141c1, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43995458008, createdName=ms2000001236693715, createdTime=Tue Feb 02 10:22:45 CST 2021, time=2021-02-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1669469, encodeId=71af166946904, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Wed Feb 24 11:01:21 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083715, encodeId=88c32083e15cc, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Tue May 25 05:01:21 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668970, encodeId=d94216689e07f, content=<a href='/topic/show?id=1086203266c' target=_blank style='color:#2F92EE;'>#不合格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20326, encryptionId=1086203266c, topicName=不合格)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77c26479803, createdName=echonoir, createdTime=Fri Jun 11 15:01:21 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922664, encodeId=2d9492266492, content=什么一起<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ec5456575, createdName=ms5000001852640370, createdTime=Thu Feb 04 00:54:54 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258792, encodeId=b34b1258e92ff, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Feb 03 16:01:21 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922141, encodeId=a7a4922141c1, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43995458008, createdName=ms2000001236693715, createdTime=Tue Feb 02 10:22:45 CST 2021, time=2021-02-02, status=1, ipAttribution=)]
    2021-02-04 ms5000001852640370

    什么一起#乳腺癌#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1669469, encodeId=71af166946904, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Wed Feb 24 11:01:21 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083715, encodeId=88c32083e15cc, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Tue May 25 05:01:21 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668970, encodeId=d94216689e07f, content=<a href='/topic/show?id=1086203266c' target=_blank style='color:#2F92EE;'>#不合格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20326, encryptionId=1086203266c, topicName=不合格)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77c26479803, createdName=echonoir, createdTime=Fri Jun 11 15:01:21 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922664, encodeId=2d9492266492, content=什么一起<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ec5456575, createdName=ms5000001852640370, createdTime=Thu Feb 04 00:54:54 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258792, encodeId=b34b1258e92ff, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Feb 03 16:01:21 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922141, encodeId=a7a4922141c1, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43995458008, createdName=ms2000001236693715, createdTime=Tue Feb 02 10:22:45 CST 2021, time=2021-02-02, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1669469, encodeId=71af166946904, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Wed Feb 24 11:01:21 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083715, encodeId=88c32083e15cc, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Tue May 25 05:01:21 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668970, encodeId=d94216689e07f, content=<a href='/topic/show?id=1086203266c' target=_blank style='color:#2F92EE;'>#不合格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20326, encryptionId=1086203266c, topicName=不合格)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77c26479803, createdName=echonoir, createdTime=Fri Jun 11 15:01:21 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922664, encodeId=2d9492266492, content=什么一起<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ec5456575, createdName=ms5000001852640370, createdTime=Thu Feb 04 00:54:54 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258792, encodeId=b34b1258e92ff, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Feb 03 16:01:21 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922141, encodeId=a7a4922141c1, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43995458008, createdName=ms2000001236693715, createdTime=Tue Feb 02 10:22:45 CST 2021, time=2021-02-02, status=1, ipAttribution=)]
    2021-02-02 ms2000001236693715

    加油

    0

相关资讯

日检测能力484万人份!全国核酸检测实现“应检尽检”“愿检尽检”

今天(8月5日)上午,国务院新闻办公室举行政策例行吹风会,工业和信息化部、科技部、卫生健康委负责人介绍提高新冠病毒检测能力有关情况。

青岛新增3例本土新冠肺炎无症状感染者

据青岛市卫健委网站消息:

战疫启示录:黑龙江省医院:布网“应检尽检”

2020年1月初,新型冠状病毒袭来,这场疫情以人们预先无法想象的速度改变着社会轨迹。

“内地核酸检测支援队”已在港陆续展开工作

香港特区政府发言人7日表示,中央政府回应特区政府要求而组成的“内地核酸检测支援队”已陆续展开工作,协助加强新冠肺炎病毒检测能力等,助力香港抗击疫情。

为了750万人的生命健康——内地支援香港核酸检测图景扫描

周五上午9时45分,香港上班族刚开始一天工作的时候,龚文波却是刚结束一天的工作。

国务院发布『核酸检测』通知!事关所有医疗机构

日前,国务院联防联控机制印发《进一步推进新冠病毒核酸检测能力建设工作方案》(以下简称《方案》)。

Baidu
map
Baidu
map
Baidu
map